Company: REVB
Filing Date: 2025-03-06
Form Type: 10-K
Source: 0000950170-25-034584
Chunk: 333

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-03-06
Form: 10-K
Item: Item 8
Chunk 333
---
 $
    —

    Fair Value of Class E Common Stock Warrants in connection with the Class D Warrant Inducement
     
    $
    4,887,683

    $
    —

    Incremental fair value of the Class D Common Stock Warrants in connection with the Class D Warrant Inducement
     
    $
    939,679

    $
    —

    Equity issuance costs in connection with the Class D Warrant Inducement included in accounts payable
     
    $
    25,968

    $
    —

    Fair Value of Class D Common Stock Warrants in connection with the February 2024 Public Offering
     
    $
    6,269,684

    $
    —

    Fair Value of Class C Common Stock Warrants in connection with the February 2023 Public Offering
     
    $
    —

    $
    13,996,500

    Alternative cashless exercise of Class C Common Stock Warrants
     
    $
    57,589

    $
    5,526,287

    Deferred offering costs included in accounts payable and accrued expenses
     
    $
    —

    $
    66,033

See accompanying notes to the consolidated financial statements.

 F-7

REVELATION BIOSCIENCES, INC.